4.8 Article

Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: implications for nanomedicine

期刊

THERANOSTICS
卷 7, 期 2, 页码 270-284

出版社

IVYSPRING INT PUBL
DOI: 10.7150/thno.16154

关键词

nanosized extracellular vesicles; exosomes; inflammation; umbilical cord mesenchymal stem cell; immunomodulation; size exclusion chromatography

资金

  1. Instituto de Salud Carlos III [FIS PI13/00050, FIS PI14/01682]
  2. SGR programme of Generalitat de Catalunya [2014SGR804, 2014SGR699]
  3. ISCIII-REDinREN [16/0009]
  4. MINECO [SAF2014-59892-R]
  5. Fundacio La Marato TV3 [201502, 201516]
  6. Red de Terapia Celular-TerCel [RD12/0019/0029]
  7. CIBER Cardiovascular [CB16/11/00403]
  8. ACCIO (Catalonia Trade Investment
  9. Generalitat de Catalunya) under the Catalonian ERDF operational program (European Regional Development Fund)
  10. Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) from the Catalan Government [2014FI B00649, 2014BP B00118]
  11. Researchers Stabilization Program from the Spanish Sistema Nacional de Salud (SNS-ISCIII)
  12. Direccio d'Estrategia i Coordinacio Catalan Health Department [CES07/015]

向作者/读者索取更多资源

Undesired immune responses have drastically hampered outcomes after allogeneic organ transplantation and cell therapy, and also lead to inflammatory diseases and autoimmunity. Umbilical cord mesenchymal stem cells (UCMSCs) have powerful regenerative and immunomodulatory potential, and their secreted extracellular vesicles (EVs) are envisaged as a promising natural source of nanoparticles to increase outcomes in organ transplantation and control inflammatory diseases. However, poor EV preparations containing highly-abundant soluble proteins may mask genuine vesicular-associated functions and provide misleading data. Here, we used Size-Exclusion Chromatography (SEC) to successfully isolate EVs from UCMSCs-conditioned medium. These vesicles were defined as positive for CD9, CD63, CD73 and CD90, and their size and morphology characterized by NTA and cryo-EM. Their immunomodulatory potential was determined in polyclonal T cell proliferation assays, analysis of cytokine profiles and in the skewing of monocyte polarization. In sharp contrast to the non-EV containing fractions, to the complete conditioned medium and to ultracentrifuged pellet, SEC-purified EVs from UCMSCs inhibited T cell proliferation, resembling the effect of parental UCMSCs. Moreover, while SEC-EVs did not induce cytokine response, the non-EV fractions, conditioned medium and ultracentrifuged pellet promoted the secretion of pro-inflammatory cytokines by polyclonally stimulated T cells and supported Th17 polarization. In contrast, EVs did not induce monocyte polarization, but the non-EV fraction induced CD163 and CD206 expression and TNF-alpha production in monocytes. These findings increase the growing evidence confirming that EVs are an active component of MSC's paracrine immunosuppressive function and affirm their potential for therapeutics in nanomedicine. In addition, our results highlight the importance of well-purified and defined preparations of MSC-derived EVs to achieve the immunosuppressive effect.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据